跳至主要内容
临床试验/NCT04412993
NCT04412993Unknown不适用

Evaluation of ABO Isoagglutinins Level in Blood Group O Donors

Assiut University0 个研究点目标入组 100 人开始时间: 2021年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
主要终点
Decrease the risk of red cell destruction resulting from transfusion of RBCs/ platelet concentrate group O transfusion in urgent cases.

研究概览

简要总结

Our study is aiming for evaluation f the titre of anti-A and anti-B in plasma of blood grop O donors, study the effect of pooling of blood product on the level of A and B isoagglutinins in blood group O donors and screening for the safest group o donors(who have the lowest anti-A antd anti-B titre) for transfusion in urgent need of blood.

详细描述

the use of O blood group transfusion to patients of all groups has continued since the second world war, nevertheless the transfusion of group O plasma/ platelet concentrate to group A, B and AB recipient sometimes causes severe red cell destruction , Acute haemolysis has been reported following transfusion of non-iso group single donor platelet (PLT) concentrates and may be more common than is appreciated.

This red blood cells destruction happens based on the fact that the sera from group O people contain two separable antibodies, anti-A and anti-B .

When it comes to PLT transfusion therapy we are dealing with issues arising from the fact that PLTs contain both significant amounts of ABO antigen on their surface, as well as anti ABO isogglutinins in the donor's plasma which caused reduction the volume of incompatible plasma administrated.

From another point of view the risk of high titer units is considered low with group O, post storage, pooled PLT concentrate. However its necessary to establish a (golden standard) method for the determination of antibody titer in order to be able to differentiate accurately the high titer donors.

So, for improving the safety of group O plts we need to define a safe level of antibody titer or reduce the volume of incompatible plasma administrated.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy adults blood group O donors

排除标准

  • Other blood groups donors.
  • Donors with history of chronic or autoimmune diseases

结局指标

主要结局

Decrease the risk of red cell destruction resulting from transfusion of RBCs/ platelet concentrate group O transfusion in urgent cases.

时间窗: 2 years

Using blood group typ "O" For other blood group types without causing any reaction resulting from blood transfusion .

次要结局

  • screening for the best group O donors to use for other groups urgent cases as a reserve for transfusion.(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

RH Ahmed

RH Ahmed

Assiut University

相似试验